FCMI
MYOK

Foresite Capital Management III’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Foresite Capital Management III’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-399,360
Closed -$54.4M – 10
2020
Q3 		$54.4M Hold
399,360
– – 40.54% 1
2020
Q2 		$38.6M Buy
399,360
+13,908
+4% +$1.16M 34.31% 1
2020
Q1 		$18.1M Buy
385,452
+58,970
+18% +$3.78M 28.77% 1
2019
Q4 		$23.8M Buy
326,482
+27,816
+9% +$1.69M 13.34% 3
2019
Q3 		$15.6M Sell
298,666
-15,734
-5% -$837K 5.95% 6
2019
Q2 		$15.8M Hold
314,400
– – 5.17% 6
2019
Q1 		$16.3M Sell
314,400
-47,041
-13% -$2.17M 4.25% 8
2018
Q4 		$17.7M Sell
361,441
-10,859
-3% -$598K 5.8% 6
2018
Q3 		$24.3M Sell
372,300
-20,489
-5% -$1.2M 5.36% 5
2018
Q2 		$19.5M Hold
392,789
– – 4.2% 8
2018
Q1 		$19.2M Buy
392,789
+87,602
+29% +$4.55M 4.18% 10
2017
Q4 		$12.8M Buy
305,187
+10,187
+3% +$393K 3.61% 8
2017
Q3 		$12.6M Buy
+295,000
New +$9.41M 3.48% 9

Foresite Capital Management III's MYOK Position: Q4 2020 in Review

Foresite Capital Management III sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 399,360 shares — an estimated $54.4M sold.

Foresite Capital Management III first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $54.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Foresite Capital Management III reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Foresite Capital Management III sold 399,360 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $54.4M.
  • Foresite Capital Management III first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
  • Foresite Capital Management III's MyoKardia, Inc. Common Stock position peaked at $54.4M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Foresite Capital Management III's 13F filing for Q4 2020, filed 16 Feb 2021.